Ehsan Parvaresh Rizi
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
Papers in
-
- Adipokines, Inflammation, and Metabolic Diseases 7
-
- Diabetes Management and Research 5
- Diabetes Treatment and Management 4
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Co-authors
- Masoud Amini (1 shared paper)Tze Ping Loh (7 shared papers)Sue‐Anne Toh (8 shared papers)Chin Meng Khoo (6 shared papers)Sonia Baig (7 shared papers)E Shyong Tai (5 shared papers)Mohammad Talaei (2 shared papers)Minoo Dianatkhah (1 shared paper)
- Journals
- Diabetes Therapy (2 papers)Frontiers in Physiology (2 papers)International Journal of Surgery (1 paper)Nutrition & Metabolism (1 paper)Diabetes (1 paper)
- Partner nations
- SingaporeUnited StatesUnited Kingdom
In The Last Decade
Ehsan Parvaresh Rizi
20 papers receiving 284 citations
Peers
Comparison fields: 5 of 67
- Endocrinology, Diabetes and Metabolism 130
- Endocrine and Autonomic Systems 19
- Physiology 71
- Epidemiology 70
- Aging 3
Countries citing papers authored by Ehsan Parvaresh Rizi
This map shows the geographic impact of Ehsan Parvaresh Rizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Parvaresh Rizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Parvaresh Rizi more than expected).
Fields of papers citing papers by Ehsan Parvaresh Rizi
This network shows the impact of papers produced by Ehsan Parvaresh Rizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Parvaresh Rizi. The network helps show where Ehsan Parvaresh Rizi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ehsan Parvaresh Rizi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 45 | |
| 2 | 2018 | 37 | |
| 3 | 2014 | 32 | |
| 4 | 2019 | 25 | |
| 5 | 2020 | 23 | |
| 6 | 2021 | 18 | |
| 7 | 2015 | 14 | |
| 8 | 2010 | 13 | |
| 9 | 2016 | 13 | |
| 10 | 2023 | 12 | |
| 11 | 2016 | 11 | |
| 12 | 2019 | 11 | |
| 13 | The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study--the Iran subgroup of the IMPROVE™ study. | 2011 | 10 |
| 14 | 2019 | 9 | |
| 15 | 2019 | 8 | |
| 16 | 2007 | 5 | |
| 17 | 2020 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2021 | 1 |
About Ehsan Parvaresh Rizi
Ehsan Parvaresh Rizi is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Physiology, Surgery and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 291 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Diabetes Management and Research (5 papers), Adipose Tissue and Metabolism (5 papers), Diabetes Treatment and Management (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Pancreatic function and diabetes (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (130 citations), Endocrine and Autonomic Systems (19 citations), Physiology (71 citations), Epidemiology (70 citations) and Aging (3 citations). Ehsan Parvaresh Rizi has collaborated with scholars based in Singapore, United States and United Kingdom. Frequent co-authors include Masoud Amini, Tze Ping Loh, Sue‐Anne Toh, Chin Meng Khoo, Sonia Baig, E Shyong Tai, Mohammad Talaei, Minoo Dianatkhah, Nizal Sarrafzadegan and Shahram Oveisgharan. Their work appears in journals such as Diabetes Therapy, Frontiers in Physiology, International Journal of Surgery, Nutrition & Metabolism and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.